Patents by Inventor Ning Chai

Ning Chai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9067979
    Abstract: The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: June 30, 2015
    Assignee: Genentech, Inc.
    Inventors: Min Xu, Mercedesz Balazs, Ning Chai, Nancy Chiang, Henry Chiu, Zhonghua Lin, Patrick Lupardus, Gerald R. Nakamura, Hyunjoo Park, Lee Swern
  • Publication number: 20150100779
    Abstract: Techniques are disclosed for accelerating online certificate status protocol (OCSP) response distribution to relying parties using a content delivery network (CDN). A certificate authority generates updated OCSP responses for OCSP responses cached in the CDN that are about to expire. In addition, the certificate authority pre-generates cache keys in place of CDNs generating the keys. The certificate authority sends the OCSP responses and the cache keys in one transaction, and the CDN, in turn, serves requests for the OCSP responses using the cache keys. For new certificates, a private CDN is pre-populated with an OCSP response for a certificate concurrent with that certificate being issued. Doing so effectively uses the PCDN as an origin server for OCSP responses, reducing CA infrastructure needs.
    Type: Application
    Filed: December 19, 2013
    Publication date: April 9, 2015
    Applicant: Symantec Corporation
    Inventors: HARI VELADANDA, NING CHAI, Richard F. ANDREWS, Quentin LIU
  • Patent number: 8894048
    Abstract: A gas diffuser including a grid of aeration pipes spaced apart and in parallel alignment within a horizontal plane is provided. The aeration pipes have improved discharge hole placement along their lengths and around their circumferences to provide improved performance and reduced fouling of membrane filtration systems associated therewith.
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: November 25, 2014
    Assignee: Dow Global Technologies LLC
    Inventors: Qixiang Cai, Ning Chai, Steven J. Gluck, Billy G. Smith, Chengfeng Wang, Quan Yuan
  • Publication number: 20140248286
    Abstract: The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.
    Type: Application
    Filed: May 12, 2014
    Publication date: September 4, 2014
    Applicant: Genentech, Inc.
    Inventors: Min Xu, Mercedesz Balazs, Ning Chai, Nancy Chiang, Henry Chiu, Zhonghua Lin, Patrick Lupardus, Gerald R. Nakamura, Hyunjoo Park, Lee Swem
  • Publication number: 20140191424
    Abstract: A gas diffuser comprises a grid of aeration pipes spaced apart and in parallel alignment with each other within a common horizontal plane and a manifold in fluid communication with the aeration pipes. A given aeration pipe (12) includes: a length (L) extending between two ends and defining an axis (Z), a hydrodynamic diameter (Dh),an elliptical cross-sectional area defining a vertical plane comprising a vertical (Y) and horizontal (X) axis intersecting through a center (C) which are perpendicular to axis (Z), an outer circumference defined by a first arc (20) comprising 30° located below the (X) axis and bisected by the (Y) axis, and a second arc (22) comprising 330° which is non-overlapping with the first arc (20.
    Type: Application
    Filed: July 9, 2013
    Publication date: July 10, 2014
    Inventors: Qixiang Cai, Ning Chai, Steven J. Gluck, Billy G. Smith, Chengfeng Wang, Quan Yuan
  • Publication number: 20140161822
    Abstract: The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.
    Type: Application
    Filed: November 12, 2013
    Publication date: June 12, 2014
    Applicant: Genentech, Inc.
    Inventors: Min XU, Mercedesz BALAZS, Ning CHAI, Nancy Chiang, Henry CHIU, Zhaoyu JIN, Zhonghua LIN, Patrick LUPARDUS, Gerald R. NAKAMURA, Hyunjoo PARK, Lee SWEM
  • Patent number: 8748373
    Abstract: A polypeptide comprising a preS1 region of hepatitis B virus (HBV), or a fragment thereof, and/or the preS2 region of HBV or a fragment thereof, and methods of use to inhibit virus infection are disclosed. A lentivirus comprising hepatitis B virus (HBV) envelope proteins, or a fragment thereof, and/or the L envelope protein of HBV and/or the M envelope protein of HBV or a fragment thereof, and/or the S envelope protein of HBV or a fragment thereof, and methods of use of this lentivirus HBV pseudovirus as a gene therapy to target hepatocytes for the administration of therapeutic agents are also disclosed.
    Type: Grant
    Filed: February 20, 2008
    Date of Patent: June 10, 2014
    Assignee: Fox Chase Cancer Center
    Inventors: Ning Chai, John M. Taylor
  • Publication number: 20140134638
    Abstract: The present invention relates to methods for enrichment of antigen-specific plasmablasts. The methods are useful for the identification of antibodies, including rare antibodies which recognize more than one antigen.
    Type: Application
    Filed: November 12, 2013
    Publication date: May 15, 2014
    Applicant: Genentech, Inc.
    Inventors: Juan ZHANG, Mercedesz BALAZS, Ning CHAI, Henry CHIU, Wyne Pun LEE, Zhonghua LIN, Patrick LUPARDUS, Lee SWEM
  • Publication number: 20110257080
    Abstract: A polypeptide comprising a preS1 region of hepatitis B virus (HBV), or a fragment thereof, and/or the preS2 region of HBV or a fragment thereof, and methods of use to inhibit virus infection are disclosed. A lentivirus comprising hepatitis B virus (HBV) envelope proteins, or a fragment thereof, and/or the L envelope protein of HBV and/or the M envelope protein of HBV or a fragment thereof, and/or the S envelope protein of HBV or a fragment thereof, and methods of use of this lentivirus HBV pseudovirus as a gene therapy to target hepatocytes for the administration of therapeutic agents are also disclosed.
    Type: Application
    Filed: February 20, 2008
    Publication date: October 20, 2011
    Inventors: Ning Chai, John M. Taylor